Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2021 Jul;194(2):267-281.
doi: 10.1111/bjh.17612. Epub 2021 Jun 27.

British Society for Haematology guidelines for the management of adult myelodysplastic syndromes

Sally B Killick  1 , Wendy Ingram  2 , Dominic Culligan  3 , Helen Enright  4 , Jonathan Kell  2 , Elspeth M Payne  5 , Pramila Krishnamurthy  6 , Austin Kulasekararaj  6 , Manoj Raghavan  7 , Simon J Stanworth  8 , Simone Green  9 , Ghulam Mufti  6 , Lynn Quek  6 , Catherine Cargo  10 , Gail L Jones  11 , Juliet Mills  12 , Alex Sternberg  13 , Daniel H Wiseman  14 , David Bowen  10
Affiliations
Practice Guideline

British Society for Haematology guidelines for the management of adult myelodysplastic syndromes

Sally B Killick et al. Br J Haematol. 2021 Jul.
No abstract available

Keywords: MDS; guideline; management; myelodysplastic syndromes.

PubMed Disclaimer

Comment in

References

    1. Killick SB, Carter C, Culligan D, Dalley C, Das-Gupta E, Drummond M, et al. Guidelines for the diagnosis and management of adult myelodysplastic syndromes. Br J Haematol. 2014;164:503-25.
    1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391-405.
    1. Roman E, Smith A, Appleton S, Crouch S, Kelly R, Kinsey S, et al. Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15. Cancer Epidemiol. 2016;42:186-98.
    1. Pfeilstöcker M, Tuechler H, Sanz G, Schanz J, Garcia-Manero G, Solé F, et al. Time-dependent changes in mortality and transformation risk in MDS. Blood. 2016;128:902-10.
    1. Sekeres MA, Maciejewski JP, List AF, Steensma DP, Artz A, Swern AS, et al. Perceptions of disease state, treatment outcomes, and prognosis among patients with myelodysplastic syndromes: results from an internet-based survey. Oncologist. 2011;16:904-11.

Publication types

MeSH terms